LISA MARIE KOUMOULOS: Open Payments
NPI 1700482866 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 35 payments from 13 companies in 2025. Trend: 2023 $726 · 2024 $543 · 2025 $829
Food & beverage: $813Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $211 |
| Lilly USA, LLC | 4 | $175 |
| Novo Nordisk Inc | 8 | $140 |
| Astellas Pharma US Inc | 4 | $69 |
| Exact Sciences Corporation | 2 | $46 |
| PFIZER INC. | 2 | $38 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Rhythm Pharmaceuticals, Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: TEZSPIRE, ZEPBOUND, Wegovy, Veozah, MOUNJARO, Cologuard Collection Kit, PAXLOVID, INSPIRE.
Industry payments across NJ — which companies pay providers there.
